Document is current
Any future updates will be listed below
-
Authors
Griebsch, Ingolf
Shrestha, Sunil https://orcid.org/0000-0002-9174-7120
Lotan, Yair
Ng, Chi-Fai
Bottomley, Andrew
-
Funding
Funding for this research was provided by:
Ferring Pharmaceuticals
- License Information
-
More Information
Article History
Received: 5 July 2025
Accepted: 15 August 2025
First Online: 13 November 2025
Declarations
:
: Yair Lotan has served as a consultant for Photocure, AstraZeneca, Merck, Fergene, Nucleix, Ambu, Seattle Genetics, Virtuoso Surgical, Stimit, Urogen, Vessi Medical, CAPs Medical, Nonagen, Aura Biosciences, Inc., Convergent Genomics, Pacific Edge, Pfizer, Phinomics Inc., CG Oncology, UroViu, Promis Diagnostics, Valar Labs, UroEssentials, NRx Pharmaceuticals, Vesica Health, Janssen, ImmunityBio, Trigone Pharma, and Relmada. Andrew Bottomley is the owner of Bottomley Consulting Group and has been funded for this specific work from Ferring Pharmaceutical company. He also has several grants and other income sources for work involving a number of pharmaceutical companies. Ingolf Griebsch is an employee of Ferring Pharmaceutical company which funded this work. Sunil Shrestha, and Chi-Fai Ng have nothing to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
